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Introduction: Long QT syndrome type 1 (LQT1) is caused by mutations in KCNQ1 coding slowly-activating
delayed-rectiﬁer Kþ channels. We identiﬁed the novel missense mutation M437V of KCNQ1 in a LQT1
patient. Here, we employed iPS cell (iPSC)-derived cardiomyocytes to investigate electrophysiological
properties of the mutant channel and LQT1 cardiomyocytes.
Methods: To generate iPSCs from the patient and a healthy subject, peripheral blood T cells were
reprogrammed by Sendai virus vector encoding human OCT3/4, SOX2, KLF4, and c-MYC. Cardiomyocytes
were prepared from iPSCs and human embryonic stem cells using a cytokine-based two-step differen-
tiation method and were subjected to patch clamp experiments.
Results: LQT1 iPSC-derived cardiomyocytes exhibited prolongation of action potential duration (APD),
which was due to a reduction of the KCNQ1-mediated current IKs; Na
þ, Ca2þ and other Kþ channel
currents were comparable. When expressed in HEK293 and COS7 cells, the mutant KCNQ1 was normally
expressed in the plasma membrane but generated smaller currents than the wild type. Isoproterenol
signiﬁcantly prolonged APDs of LQT1 cardiomyocytes, while shortening those of healthy ones. A math-
ematical model for IKs-reduced human ventricular myocytes reproduced APD prolongation and gener-
ation of early afterdepolarizations (EADs) under b-adrenergic stimulation.
Conclusions: QT prolongation of the LQT1 patient with the mutation M437V of KCNQ1 was caused by IKs
reduction, which may render the patient vulnerable to generation of EADs and arrhythmias.
© 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).EAD, early afterdepolarization; EB, embryoid body; ESC, embryonic stem cell; HP, holding potential; ICaL, L-type Ca2þ
er Kþ channel current; IKs, slowly-activating delayed-rectiﬁer Kþ channel current; IK1, inward-rectiﬁer Kþ channel
luripotent stem cell; LQTS, long QT syndrome; TdP, Torsade de points.
: þ81 76 286 8010.
ata).
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Long QT syndrome (LQTS) is characterized by prolonged QT
intervals in ECG. It causes a speciﬁc form of tachycardia, Torsade de
Pointes (TdP), which is driven by triggered activity through early
afterdepolarization (EAD) and can cause sudden cardiac death
[1e3]. LQTSs are classiﬁed into congenital and acquired ones [4].
Previous reports described at least 15 different forms of congenital
LQTSs, 45% of which are caused by mutations in KCNQ1 (KvLQT1 or
Kv7.1) and classiﬁed as LQTS type 1 (LQT1) [4e7]. KCNQ1 encodes
the alpha subunit of the channel generating slowly-activating
delayed-rectiﬁer Kþ currents (IKs) that are responsible for the
repolarization of ventricular myocytes [2]. Mutations of KCNQ1
can cause (1) a reduction of KvLQT1 channel density on the plasma
membrane due to trafﬁcking defect and/or (2) impaired conduc-
tance of channels expressed in the plasma membrane. Heterolo-
gous expression systems and genetic animal models have been
utilized to study the impacts of each mutation on protein traf-
ﬁcking and channel functions. However, they have several disad-
vantages such as artiﬁcial effects caused by overexpression of ion
channels and inabilities to evaluate contributions of mutant
channels to the action potential (AP) conﬁguration in human
cardiomyocytes [8,9]. Induced pluripotent stem cells (iPSCs) offer
a unique opportunity to study the pathogenesis of a disease and
screen appropriate therapeutic drugs [10]. Many studies have
already shown that cellular phenotypes of inherited disorders are
recapitulated by disease-speciﬁc iPSCs in vitro, and LQTSs are not
exceptions [10,11].
We found a novel mutation, M437V, of KCNQ1 in a LQT1 patient.
iPSCs were established from his T lymphocytes and differentiated
into cardiomyocytes for analyzing their electrophysiological prop-
erties. The experimental results indicated an impaired activity of
the mutant KvLQT1 channels to cause prolongation of AP durations
(APDs); b-adrenergic stimulation (b-AS) augmented APD prolon-
gation, while not inducing EADs. Computer simulations using a
mathematical model of human ventricular myocytes suggested that
EADs and arrhythmic behaviors could emerge in the mid-
myocardial (M) cell layer of the ventricle when additional condi-
tions to further prolong APDs occur.2. Materials and methods
2.1. Patient consent
All subjects provided informed consent for genetic tests asso-
ciated with LQTS. This studywas approved by the Ethics Committee
of Tottori University. It also conforms with the principles outlined
in the Declaration of Helsinki for use of human tissue or subjects.2.2. Establishment of T cell-derived iPSCs (TiPSCs) and culturing
human embryonic stem cells (ESCs)
iPSCs were established as described previously [12]. Mono-
nuclear cells were separated from the patient's blood by
FicollePaque PREMIUM (GE Healthcare). They were plated at
3.0  104 cells/cm2 in 6-well plates coated with anti-human CD3
antibody (BD Pharmingen). They were incubated at 37.0 C, with
3.0% CO2 conditions. Cells were infected with Sendai virus carrying
Yamanaka factors (DINAVEC); transfectants were plated at 5.0 105
in dish (MEF feeder) in the maintenance medium described pre-
viously [13,14], and cultured for 4 weeks. ESC-like colonies were
transferred to 24-well plates on mouse embryonic ﬁbroblast
feeders. TiPSCs and human ESCs were cultured following the
method of culturing human ESCs described by Suemori et al. [13].2.3. Differentiation of TiPSCs and ESCs into cardiomyocytes
TiPSCs and human ESCs were differentiated into cardiomyocytes
according to the protocol described by Yamauchi et al. [14]. In the
process of iPSC induction from LQT1 patient T cells, 4 iPSC lines
with typical stem cell morphology were selected and subjected to
cardiac differentiation. We ﬁnally chose 2 lines (#b and #e) as
patient-derived iPSC lines because they showed better cardiac
differentiation. Both the cell line #b and #e showed very similar
LQT1 phenotypes; the line #e was used as a representative. The
same strategy was also applied for selection of healthy subject-
derived iPSC lines, and the line #3 was used for analyses in this
study.2.4. Immunostaining
The primary antibodies for OCT4, SOX2, NANOG, TRA-1-60,
TRA1-81, SSEA4 and tropomyosin used were Stem Light Pluripo-
tency Antibody Kit (Cell Signaling Technology Danvers Massachu-
setts, USA) and MONOCLONAL ANTI-TROPOMIOSIN
(SigmaeAldrich, St Louis, MO, USA). To detect OCT4, SOX2, NANOG,
TRA-1-60, TRA-1-81, SSEA4 and tropomyosin, ﬁxed cells were
stained with indicated monoclonal antibodies. Alexa Flulor 488-
labeled or 546-labeled IgG (Molecular Probes Invitrogen, Carls-
bad, CA) was used as the secondary antibody.2.5. RT-PCR assay
Total RNAs were isolated using an RNeasy Micro Kit (QIAGEN,
Tokyo, Japan). cDNAs were synthesized using PrimeScript® RT re-
agent Kit with gDNA Eraser Perfect Real Time (TaKaRa BIO, Otsu,
Japan). RT-PCR was performed using EmeraldAmp® MAXPCR
Master Mix (TaKaRa). Primer sequences are listed in the
Supplemental Table 1.2.6. Karyotype analysis
Karyotypes of iPSCs derived from the patient and healthy sub-
ject were determined using the standard Q-banding chromosome
analysis.2.7. Genomic sequencing
Genomic DNA was isolated from blood samples and TiPSCs
derived from the patient and healthy subject. The KCNQ1 gene
fragment was ampliﬁed by PCR and subjected to sequencing.2.8. Plasmid construction and transfection
cDNAs encoding KCNQ1 were cloned in the plasmid pcDNA3.1
to create pcDNA3.1/KCNQ1. The mutation was introduced by site-
directed mutagenesis. cDNAs encoding wild-type (WT) or M437V
mutant KCNQ1 were ligated into the multiple cloning sites at
pIRES-EGFP (Clontech, Mountain View, CA, USA) to create
pIRES2-EGFP/WT KCNQ1 and pIRES2eEGFP/M437V KCNQ1.
cDNAs encoding KCNE1 were also cloned in the pcDNA3.1. Both
HEK293 and COS7 cells were cultured and co-transfected with
pAcDsRed-Mem (membrane marker) and either pIRES2-EGFP/
WT KCNQ1 or pIRES2eEGFP/M437V KCNQ1 together with
pcDNA3.1/KCNE1 using lipofectamine (Invitrongen, Carlsbad, CA,
USA). Cells were collected at 48 h after transfection and were
subjected to assays.
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APs and ion channel currents weremeasured in the beating cells
enzymatically isolated from embryoid bodies (EBs) under current
clamp mode and voltage clamp mode, respectively, using the
whole-cell patch-clamp technique. In the present study, we selec-
tively collected ventricular type cells based on the morphological
and electrophysiological criteria reported previously, i.e., elongated
cells with an oval nucleus, well organized tension-oriented myo-
ﬁbrils spanning the long axis, relatively long AP plateau phase, and
negative maximum diastolic potentials [15]. The external solution
used to measure APs and ionic currents in iPSC-derived car-
diomyocytes was the differentiation-inducing culture medium
[13,14]. COS7 cells co-expressing KCNQ1 and KCNE1, visualized by
GFP ﬂuorescence, were also subjected to the whole-cell patch
clamp tomeasure theWT KCNQ1/KCNE1 or M437V KCNQ1/KCNE1-
medicated current corresponding to IKs in the culture medium.
The glass pipettes had a resistance of 6e8 MU after ﬁlling with
the internal pipette solution containing (in mM) 100 K-aspartate,
20 KCl,1 CaCl2, 5Mg-ATP, 5 ethylene glycol bis(2-aminoethylether)-
N,N,N0,N’-tetraacetic acid (EGTA), 5 HEPES, and 5 creatine phos-
phate (pH 7.2 with KOH). Currents were recorded using an
Axopatch-200B ampliﬁer (Axon Instrument, USA) and directly
stored in a personal computer (NEC Mate, Japan) at 10 kHz. The
capacity-corrected data were digitally ﬁltered at 2 kHz and
analyzed with the pCLAMP9 software.
Outward membrane currents of IKs and KCNQ1/KCNE1-
medicated currents were elicited every 6 s by 4000-ms depolariz-
ing test pulses ranging from40 toþ60 mV (in 10 mV increments),
which were followed by 1500-ms repolarization to 40 mV for
recording tail currents. A holding potential (HP) was 60 mV. IKs in
iPSC- and ESC-derived cardiomyocytes was measured as a chro-
manol 293B-sensitive current, separated by applying chromanol
293B at 50 mM.
Voltage dependence of IKs activation determined by measure-
ments of the tail current amplitude during repolarizing pulses was
ﬁtted by a Boltzmann equation as a function of membrane poten-
tials (Vm):
IKs,tail ¼ 1/{1 þ exp[(VmVh)/s]}, (1)
where IKs,tail represents the current amplitude normalized to the
maximum attainable current. Vh and s denote the half-maximum
voltage and slope factor, respectively.
Naþ channel current (INa) and Ca2þ channel current (ICa) were
elicited at 0.2 Hz by 100-ms depolarization to 80 ~ þ60 mV (in
10 mV increments) from a HP of 90 and 50 mV, respectively.
Rapidly-activating delayed-rectiﬁer Kþ channel current (IKr) was
evoked by 200-ms test pulses ranging from 40 to þ50 mV (in
10 mV increments) from a HP of 80 mV; tail currents of IKr were
measured by clamping back to 50 mV. In addition, the inward-
rectiﬁer Kþ channel current (IK1) was recorded using a ramp
pulse protocol with a functional generator (FG-122, NF Corpora-
tion). The ramp pulses ranging from 120 to 0 mV were applied at
1.5 V/s every 3 s. For cells with automaticity, the beating rate was
measured by a time lapse imaging system (LCV110, Olympus). All
experiments were carried out at 37 C.
2.10. Statistical analysis
All values are presented as the mean ± S.E.M. For statistical
analysis, repeated-measures analysis of variance (two-way ANOVA)
was used, with p < 0.05 considered statistically signiﬁcant. Statis-
tical analyses and nonlinear curve ﬁttings were performed with
Origin 8.5 (OriginLab, MA, USA).2.11. Computer simulations of APs of human cardiac myocytes
We simulated prolongation of APDs and EAD generations in
LQT1 cardiomyocytes using a mathematical model of human
ventricular myocytes developed by Kurata et al. [16]. A M cell
version of the model cell was developed on the basis of the
transmural heterogeneity in densities of ion channels and trans-
porters as summarized by O'Hara et al. [17]. We employed the M
cell version, because it has larger ICaL, as well as smaller IKr and IKs,
thus being much more vulnerable to EAD formation than the
endocardial and epicardial versions [17]; it was most advantageous
to recapitulating EADs under the conditions of b-AS and arrhyth-
mogenicity of LQT1. APs were elicited by 1-ms stimuli of 60 pA/pF
at 1 Hz. For simulating the conditions of b-AS as a major trigger of
EADs and TdP in LQT1, parameters describing the maximum
conductance of ion channels and density of transporters were
modiﬁed on the basis of previous reports [18,19] as follows: (1) the
maximum ICaL conductance (gCaL) increased to 200e350% of the
control; (2) the maximum IKs conductance (gKs) increased twice
with the voltage dependence of activation kinetics negatively
shifted by 8 mV; (3) Naþ-Kþ pump current density increased by
20%; and (4) sarcoplasmic reticulum Ca2þ pumping rate increased
by 41%.
3. Results
3.1. Clinical characteristics of the patient
An 18-year-old man was diagnosed as LQTS by standard 12-
lead ECG, which showed a prolonged heart rate-corrected QT
interval (QTc) of 462 ms as compared with the QTc (381 ms) of
one healthy volunteer (Fig. 1A). The ECG suggested the diagnosis
of LQT1. His father and sister, who also have the same M437V
mutation, showed similar QT interval abnormality (Fig. 1B). There
were no abnormal ﬁndings in chest X-ray, ultrasonic cardiogram
or treadmill exercise test. Direct sequencing of KCNQ1 alleles
identiﬁed a mutation, A1309G, in one allele (Fig. 1C), which
causes the M437V mutation in KCNQ1 (Fig. 1D). No mutation was
found in the major LQTS-related genes KCNH2, SCN5A, KCNE1 or
KCNE2.
3.2. Generation of iPSCs
To generate iPSCs, we used T lymphocytes from the LQT1 pa-
tient and healthy volunteer; they were reprogrammed by Sendai
virus-mediated gene transfer of OCT3/4, SOX2, KLF4, and c-MYC.
Several clones were generated, expanded, and stored. As exem-
pliﬁed in the supplemental Fig. S1A, all iPSC lines showed typical
iPSC morphology. Qualitative RT-PCR conﬁrmed that all lines
expressed pluripotency markers such as OCT3/4, SOX2, KLF4, c-
MYC and NANOG, as well as silenced exogenous genes (Fig. S1B).
Immunohistochemistry also conﬁrmed expressions of the plurip-
otency markers OCT3/4, SOX2, SSEA4, TRA-1-60, TRA-1-81 and
NANOG (Fig. S1C). Chromosome analysis showed no abnormality
of their karyotypes (supplemental Fig. S2). We selected two clones
of iPSCs from the LQT1 patient and two clones of iPSCs from the
healthy subject for further characterizations after cardiac
differentiation.
3.3. Differentiation of iPSCs and human ESCs into cardiomyocytes
iPSCs and human ESCs were differentiated into car-
diomyocytes in EBs. Cells in EBs started spontaneous beating in 1
week after formation of EBs. There was no signiﬁcant difference in
characteristics of iPSC-derived cardiomyocytes between the LQT1
Fig. 1. Characterization of a LQT1 patient with the M437V mutant KCNQ1. (A) ECGs of the LQT1 patient and a healthy subject as a control, which show the QTc values of 462 and
381 ms, respectively. (B) The family pedigree of the proband with LQT1. The arrow indicates the patient. The members with the M437V mutation and QT prolongation are shown in
red. (C) A novel KCNQ1 mutation of A1309G (M437V) in the LQT1 patient. The sequence analysis of genomic KCNQ1 obtained from blood of the patient and healthy subject revealed
a heterozygote missense mutation (A/G) at the position 1309 of the KCNQ1 coding region (A1309G). (D) A schematic representation of the mutant KCNQ1 protein, indicating the
substitution of the uncharged valine for the positively charged methionine at the position 437 of the cytoplasmic C-terminal domain (M437V).
T. Sogo et al. / Regenerative Therapy 4 (2016) 9e1712patient and healthy subject: Both EBs developed from healthy
subject-derived and LQT1 patient-derived iPSCs showed similar
mRNA levels of TnT, MYH6, MYL2, MYL7, KCNQ1 and KCNE1 as
evaluated by RT-PCR (Fig. 2A). Enzymatically dissociated car-
diomyocytes were positively stained with anti-tropomyosin
antibody (Fig. 2B).Fig. 2. Cardiac differentiation of iPSCs obtained from the LQT1 patient (M437V) and hea
diomyocytes differentiated from iPSCs of the patient and healthy subject. (B) Representati
entiated from the patient and healthy subject iPSCs.3.4. Comparison of electrophysiological properties of
cardiomyocytes derived from healthy subject iPSCs, LQT1 patient
iPSCs and human ESCs
Fig. 3A shows the representative traces of ventricular type APs
recorded from a healthy subject and an LQT1 patient iPSC-derivedlthy subject (WT). (A) Representative mRNA expressions of cardiac markers in car-
ve immunoﬂuorescence analysis of tropomyosin expression in cardiomyocytes differ-
T. Sogo et al. / Regenerative Therapy 4 (2016) 9e17 13cardiomyocyte as well as a human ESC-derived cardiomyocyte.
APDs were longer in the LQT1 iPSC-derived cardiomyocyte than in
the healthy iPSC- and human ESC-derived one. There were no dif-
ferences in diastolic membrane potentials among them. Fig. 3B
shows summary data of APDs at 50% repolarization (APD50) and
90% repolarization (APD90) obtained from 15 healthy and 15 LQT1
iPSC-derived cardiomyocytes as well as 15 human ESC-derived
ones. APDs were signiﬁcantly longer in LQT1 iPSCs-derived
cardiomyocytes.
Fig. 4A shows representative outward membrane currents
recorded from a healthy and an LQT1 iPSC-derived cardiomyocyte
as well as a human ESC-derived one. These currents were almost
completely blocked by 50 mM chromanol 293B (data not shown),
indicating that they correspond to IKs. The amplitude of IKs
measured as a chromanol 293B-sensitive current was smaller in
LQT1 iPSC-derived cardiomyocytes than in the others; time cour-
ses of voltage-dependent activation and deactivation were com-
parable. Voltage dependences of IKs activation measured at the
end of depolarizing test pulses are summarized in Fig. 4B. Fig. 4C
shows voltage dependences of the tail current amplitude
measured as the maximum at the beginning of each repolarizing
pulse and normalized to the maximal attainable current at the
most depolarized potential (þ60 mV) for the three types of car-
diomyocytes. The sigmoidal curves are the ﬁts by the Boltzmann
equation (Eq. (1)). They overlapped with each other with similar
time constants of activation and deactivation, indicating the
normal gating kinetics of IKs channels in the LQT1 cardiomyocyte.
IKs amplitudes at þ60 mV were 11.33 ± 1.76 pA/pF for the healthy
iPSC-derived cardiomyocyte and 4.99 ± 0.54 pA/pF for the M437V
iPSC-derived one; thus, the maximum conductance of the mutant
channel was estimated to be 44% of the normal one. As shown in
the supplemental Fig. S3, INa, ICa, IKr or IK1 showed no signiﬁcant
differences in amplitude or kinetics among the three types of
cardiomyocytes. Taken together, the LQT1 iPSC-derived car-
diomyocyte had speciﬁc reductions in conductance of KvLQT1-
mediated IKs.Fig. 3. Action potential (AP) properties of iPSC-derived cardiomyocytes (TiPS-CM) obtained f
ones (hES-CM). (A) Representative spontaneous APs recorded from differentiated cardiomy
repolrarization (APD90) from the 3 types of cardiomyocytes (n ¼ 15 each).3.5. Characterization of heterologously-expressed mutant KCNQ1
proteins and channels
Some mutations of KCNQ1 impair protein trafﬁcking, resulting
in reduced expression of KCNQ1 on the plasma membrane. To
examine the intracellular trafﬁcking of M437V mutant KCNQ1
proteins, they were expressed in HEK293 cells. As illustrated in
Fig. 5, both signals of the WT and mutant KCNQ1-GFP similarly
merged with the signals of membrane markers, indicating their
normal trafﬁcking to the plasma membrane. We also measured
KCNQ1-mediated currents in COS7 cells expressing the WT or
mutant KCNQ1-GFP. Fig. 6A shows representative traces of KCNQ1-
mediated currents in COS7 cells transfected with either the WT or
mutant KCNQ1 plasmid. As shown in Fig. 6B summarizing the
voltage-dependent activation of KCNQ1-mediated currents, the
amplitude of the mutant KCNQ1-mediated currents was signiﬁ-
cantly smaller than that of the WT currents.
3.6. Effects of isoproterenol on AP properties of LQT1 iPSCs-derived
cardiomyocytes
Fig. 7 shows the effects of isoproterenol on AP waveforms of
cardiomyocytes derived fromhealthy and LQT1 iPSCs. Isoproterenol
(100 nM) remarkably prolonged APDs of LQT1 iPSC-derived car-
diomyocytes, while shortening APDs of healthy iPSC-derived ones.
3.7. Computer simulations of APD prolongation and EAD generation
in LQT1 cardiomyocytes
Fig. 8A shows simulated APs of the normal and LQT1 model
cardiomyocytes (M cells) under the basal (control) condition and
conditions of b-AS with gCaL increased by 100, 200 or 250%. LQT1
model cells were developed by reducing gKs to 44% and 24% of the
control, according to the current density data for the M437V
mutation (Fig. 4) and the previous report for the A590Wmutation
[20], respectively. The LQT1 model cells showed longer APDsrom the LQT1 patient (M437V) and healthy subject (WT) as well as human ESC-derived
ocytes. (B) Summary data of the AP duration at 50% repolrarization (APD50) and 90%
Fig. 4. Kinetic properties of IKs in iPSC-derived cardiomyocytes (TiPS-CM) obtained from the LQT1 patient (M437V) and healthy subject (WT) as well as human ESC-derived ones
(hES-CM). (A) Representative original traces of chromanol 293B-sensitive currents corresponding to IKs, which were elicited by the depolarizing test pulses ranging from 40
to þ60 mV in the presence of 50 mM chromanol 293B. (B) Voltage dependence of IKs activation. The amplitudes of currents at the end of depolarizing test pulses were determined
and plotted against the test potentials for the 3 types of cardiomyocytes (n ¼ 15 each). (C) Voltage-dependent activation of the tail currents. The maximum current amplitudes
determined at the beginning of repolarizing pulses were normalized to the maximum attainable current and plotted against depolarizing test potentials for the 3 types of car-
diomyocytes (n ¼ 15 each). The curves are the ﬁts with the Boltzmann equation (Eq. (1)); the half-maximum potentials estimated for the patient (M437V) iPSC-, healthy (WT) iPSC-
and human ESC-derived cardiomyocytes were 9.08, 9.17 and 9.57 mV, respectively.
T. Sogo et al. / Regenerative Therapy 4 (2016) 9e1714under the basal condition (429 ms in normal vs. 486 ms in M437V
and 525 ms in A590W) and EAD generations under b-AS with gCaL
increased by 250% in M437V and 100% (or more) in A590W,
whereas the normal cell never exhibited EADs. Susceptibility of
the normal and LQT1 cardiomyocytes to EAD generation during b-
AS is compared in Fig. 8B, where critical values of gCaL for EAD
generation (and EAD termination leading to repolarization fail-
ure) are plotted as a function of gKs. EAD generation via gCaL in-
creases during b-AS can be avoided by concomitant gKs increases
in the normal cell, but not in the LQT1 cells. The gCaL increase
required for EAD formation is larger in M437V (250%) than in
A590W (90%). As shown in the supplemental Fig. S4 for M437V,Fig. 5. Expressions of the wild-type (WT) and M437V mutant KCNQ1-GFP in HEK293 cells c
or M437V KCNQ1-GFP and a membrane marker, AcDsRed-Mem.however, concomitant reductions in the maximum IKr conduc-
tance (gKr) dramatically lower the critical gCaL value to cause
EADs. Susceptibility of the cardiomyocytes to EAD generation was
also tested for inhibition of IKr alone without b-AS (supplemental
Fig. S5). The distances from the control condition to the critical
point to cause EADs during increases in gCaL or decreases in gKr,
i.e., the degrees of gCaL increases or gKr decreases required for EAD
formation are much smaller in the LQT1 model cells than in the
normal one. These results indicate that susceptibility to EAD
generation during b-AS (enhancement of ICaL) and/or inhibition of
IKr was much higher in the LQT1 cardiomyocytes than in the
normal one.o-expressing WT KCNE1. Shown are representative immunoﬂuorescence images of WT
Fig. 6. Membrane currents mediated by the WT and M437V mutant KCNQ1 expressed
in COS7 cells. (A) Representative traces of WT and M437V KCNQ1-mediated currents in
COS7 cells co-expressing WT KCNE1. (B) Voltage-dependent activation of WT and
M437V KCNQ1-mediated currents. The amplitudes of currents at the end of depola-
rizing test pulses were determined and plotted against test potentials for COS7 cells
expressing WT KCNQ1-GFP (n ¼ 7) or M437V KCNQ1-GFP (n ¼ 5) together with WT
KCNE1.
T. Sogo et al. / Regenerative Therapy 4 (2016) 9e17 154. Discussion
In the present study, we developed iPSCs and iPSC-derived
cardiomyocytes from T cells of a case with familial LQT1
harboring the missense mutation M437V of KCNQ1 in order to
determine electrophysiological properties of cardiomyocytes withFig. 7. Effects of isoproterenol (ISP) on APs of cardiomyocytes derived from healthy (WT) a
absence (green/blue) and presence (black) of 100 nM ISP. (B) Summary data of changes i
determined before and after a 5 min application of ISP; the value with ISP (ISP(þ)) was northe mutant KCNQ1. Infection by Sendai virus harboring Yamanaka 4
factors generated iPSCs without any genome injury [12]. Obtained
iPSCs expressed mRNA of the endogenous pluripotent markers
without residual exogenous Sendai virus vectors (Fig. S1B). Plu-
ripotency has been conﬁrmed by protein expressions of the
pluripotent markers (Fig. S1C). iPSCs from the patient as well as a
healthy subject differentiated into cardiomyocytes in EBs (Fig. 2).
KvLQT1 channels coded by KCNQ1 confer IKs, which is respon-
sible for repolarization of cardiomyocytes. Mutations of KCNQ1 to
cause LQT1 can reduce IKs and prolong APDs by two mechanisms:
1) impaired trafﬁcking of KCNQ1 proteins to the plasma membrane
[7,10], and 2) impaired functions of channel proteins expressed in
the membrane [21]. Compared with the healthy iPSC- and human
ESC-derived cardiomyocytes, the cardiomyocytes derived from the
LQT1 patient iPSCs showed a signiﬁcant reduction in IKs and pro-
longed APDs without differences in INa, ICa, IKr or IK1. There was no
difference in trafﬁc between the mutant and WT KCNQ1 proteins
when expressed in HEK293 cells. KCNQ1-mediated currents were
signiﬁcantly smaller in COS7 cells transfected with the mutant
KCNQ1 than in those transfected with the WT. Taken together, the
mutation M437V reduced IKs and prolonged APDs via the second
mechanism. There was no signiﬁcant difference in voltage-
dependent kinetics of IKs between the LQT1 and healthy cells,
suggesting that the single channel conductance is reduced in the
mutant channel. Single channel recordings are necessary to further
characterize the electrophysiological properties of the mutant
channel.
A KCNQ1 subunit has six transmembrane domains with intra-
cellular N- and C-termini [7]. IKs channels are constructed by tet-
ramers of KCNQ1 subunits with or without a KCNE1 subunit, a
single transmembrane domain peptide [22e26]. It is predicted that
the C-terminal domain of KCNQ1 contains four a-helices (helices A,
B, C and D), which play an important role in protein folding,
tetoramerization and KCNE1 binding. Helices A and B harbor
binding sites for calmodulin that is responsible for proper folding of
the C-terminal region [24,27,28], whereas helices C and D play annd LQT1 (M437V) iPSCs. (A) Representative APs of iPSC-derived cardiomyocytes in the
n APDs by 100 nM ISP (n ¼ 10 each). APD90 values (averages from three APs) were
malized to the control value (ISP()). *p < 0.05 vs. each control (ISP()), paired t-test.
Fig. 8. ICaL-dependent electric behaviors of the normal and LQT1 ventricular myocyte (M cell) models under b-AS. The LQT1 model cells were developed by reducing gKs to 44%
(M437V) and 24% (A590W) of the control. For simulating the conditions of b-AS, parameters other than the maximum conductance of ICaL (gCaL) and IKs (gKs) were modiﬁed on the
basis of the previous reports as stated in the Methods section. (A) Simulated APs of the model cells under the basal condition and conditions of b-AS with gCaL increased to 200, 300
or 350% of the control value. Model cells were paced at 1 Hz with 1-ms stimuli of 60 pA/pF for 30 min; the AP responses evoked by the last 6 stimuli are shown. The horizontal and
vertical solid lines indicate 1 s and 40 mV, with the dashed lines denoting the 0 mV level. (B) Critical values of gCaL for the initiation (EAD1) and termination (EAD2) of EADs plotted
as a function of gKs. The point for EAD termination (EAD2) was determined as the point at which repolarization failure (i.e., low-voltage oscillations or arrest at depolarized po-
tentials) occurred. The maximum conductance of each current is indicated as a ratio to the control value. The model cell was paced at 1 Hz with 1-ms stimuli of 60 pA/pF for
1e2 min at each parameter set. The critical points were determined during gCaL increases under b-AS at various gKs values. The parametric planes were divided into 3 areas by the
loci of the critical points: (1) normal APs (Area 1), (2) APs with EADs (Area 2), and (3) repolarization failure (Area 3). The points of the control conditions for cardiomyocytes with the
normal, M437V mutant and A590W mutant IKs are labeled as “N”, “MV” and “AW”, respectively, with the arrows indicating the b-AS-induced parameter shifts from the control
condition to the points (parameter sets) at which AP behaviors were tested as shown in Panel A.
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reports indicated that mutations of KCNQ1 located in the helices A
and B led to the impaired stability of KCNQ1, resulting in the
impaired membrane trafﬁcking [23,26]. In the present study,
however, the M437V mutation located in the ﬂanking region of
helices A and B led to a reduction in channel currents with normal
trafﬁcking. Thus, this is the ﬁrst report indicating that a mutation in
the region of helices A and B can inﬂuence the conductance of
KCNQ1-mediated channel currents without impaired trafﬁc to the
plasma membrane.
It remains unknown whether the impaired functions of KvLQT1
channels could underlie the prolongation of ventricular APD and
QTc in the present case. As demonstrated by the computer simu-
lation using the human ventricular myocyte model, the 56%
reduction of the KvLQT1 channel current IKs as observed in this
mutation (Fig. 4) yielded the 13.4% prolongation of human ven-
tricular (M cell) APDs during 1 Hz pacing. This result suggests that
the reduction of IKs observed in the present LQT1 iPSC-derived
cardiomyocytes could underlie the prolongation of ventricular
APD and QTc.
It is also an issue whether this impaired IKs channel activity
could lead to arrhythmogenicity in the present case, since the
present case did not have a medical history of TdP or syncope. The
previous studies reported that isoproterenol, as well as the IKr in-
hibitor E4031, induced triggered activities following EADs in thecardiomyocytes derived from iPSCs of LQT1 patients, which have
been prevented by pretreatment with b-blockers [7,10]. In our ex-
periments using iPSC-derived cardiomyocytes with the M437V
mutation, administration of isoproterenol and/or E4031 prolonged
APDs but did not induce EADs or arrhythmic behaviors, which
might support less arrhythmogenicity in the present case. Based on
our simulations (Fig. 8, S4 and S5), however, EADs may occur in this
LQT1 patient when a larger increase in ICaL is induced by stronger b-
AS (e.g., via catecholamine administration) and/or when IKr is
inhibited (e.g., by application of calss III antiarrhythmic agents).
Greater enhancement of ICaL and/or greater inhibition of IKr were
required for EAD formation in M437V (44% gKs) than in A590W
(24% gKs), whichmay account for the lack of a medical history in the
present case. Nonetheless, the impaired activity of the M437V
mutant IKs as estimated from iPSCs-derived cardiomyocytes may
lead to generation of EADs and resultant TdP during b-AS in com-
bination with concomitant inhibitions of IKr or delay in b-AS-
induced IKs increases, although it could not induce EADs or TdP
under basal conditions or relatively weak b-AS. These ﬁndings
might be useful in managing the risk of this case and also explain
the less arrhythmogenicity (lack of clinical events) in the present
case.
Priori et al. stratiﬁed clinical risk according to the genotype, in
conjunction with other clinical variables such as sex and length of
the QT interval [29]. The QTc was an independent predictor of risk
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event-free survival was greater in both male and female patients
with QTc of <500 ms than in those with QTc of >500 ms. The
present case showed the QTc less than 500 ms (462 ms) without
any family history of sudden cardiac death, predicting the less
chance of cardiac events. As suggested by the simulation study
(Fig. 8, S4 and S5), however, the LQT1 patient with the M437V
mutation would be much more vulnerable to the generation of
EADs and TdP than healthy subjects, especially under pathophysi-
ological and/or therapeutic conditions, such as hypokalemia and
administration of catecholamine and/or class III antiarrhythmic
agents, leading to further increases in QTc [30].
It is obvious that the present study includes a certain limitation.
Comparison of iPSCs generated from patients with those from
healthy control is not reasonable, because the inﬂuences of gene
polymorphisms other than the focusedmutation could not be ruled
out. It is most reasonable to make isogenic control using genome
editing technologies such as CRISPR/Cas9 or TALEN for elucidating
pure effects of theM437Vmutation; however, we did not create the
isogenic control in this study. To compensate for this limitation, we
evaluated electrophysiological properties of the human ESC-
derived cardiomyocyte as another control, which is frequently
used as a control for comparisons to iPSC-derived ones [31]. The
electrophysiological properties of human ESC-derived car-
diomyocytes were comparable to those of healthy iPSC-derived
ones.
5. Conclusion
This study has demonstrated for the ﬁrst time that a mutation in
the KCNQ1 region of helices A and B can reduce the conductance of
KCNQ1-mediated IKs channel currents without trafﬁcking defect.
The reduced IKs of theM437Vmutant channel could account for the
prolongation of APD in iPSC-derived cardiomyocytes and QTc in
ECG of the patient. The lack of a medical history in this case might
be due to the relatively small reduction in current amplitude of the
mutant channel; however, the patient would be much more
vulnerable to the generation of EADs and TdP than healthy subjects
under pathophysiological and/or therapeutic conditions. The pre-
sent study indicates that a combination of electrophysiological
study using LQT1 iPSC-derived cardiomyocytes and computer
simulation study is useful not only for elucidating the mechanisms
of arrhythmogenicity in LQTSs but also for evaluation of future risk
for arrhythmias.
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